Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMNHSI8)

Drug Name

PCO371 Drug Info

Synonyms

Pco-371; UNII-TE53TU0WSQ; TE53TU0WSQ; PCO-371; 1613373-33-3; SCHEMBL17104864; CHEMBL3976807; US9428505, Compound 7; BDBM64562; PC-0371; J3.591.565F; 2,4-Imidazolidinedione, 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro(4.5)dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethyl-

Indication

Disease Entry	ICD 11	Status	REF
Hypoparathyroidism	5A50	Phase 1	[1]

Cross-matching ID

PubChem CID: 76283707
CAS Number: CAS 1613373-33-3
TTD Drug ID: DMNHSI8

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Parathyroid hormone 1 receptor (PTH1R)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Abaloparatide	DMOERGM	Postmenopausal osteoporosis	FB83.11	Approved	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Parathyroid hormone 1 receptor (PTH1R)	TTFPD47	PTH1R_HUMAN	Agonist	[1]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.